ProCE Banner Activity

Medical Minute 2: Current and Emerging Therapies for Advanced NSCLC With HER2 Mutations and HER2 Overexpression

Slideset

Download this slideset on current and emerging treatment options for patients with advanced NSCLC and HER2 alterations.

Released: October 17, 2024

Expiration: October 16, 2025

Share

Faculty

Misako Nagasaka

Misako Nagasaka, MD, PhD

Associate Clinical Professor
Division of Hematology/Oncology
Department of Medicine
University of California Irvine School of Medicine
Orange, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.